Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 8/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1324548 | 0.98 | CYP1A2 (0.39) | CYP1A2NAAATSHRTHRBEPHX1 | |
| SCHEMBL1323174 | 0.98 | CYP1A2 (0.39) | CYP1A2NAAATSHRTHRBEPHX1 | |
| SCHEMBL9017493 | 0.98 | CYP1A2 (0.44) | CYP1A2NAAAEPHX1SIGMAR1EPHX2 | |
| SCHEMBL1323135 | 0.95 | CYP1A2 (0.43) | CYP1A2NAAATSHRTHRBEPHX1 | |
| SCHEMBL31561599 | 0.95 | CYP1A2 (0.43) | CYP1A2NAAATSHRTHRBEPHX1 | |
| SCHEMBL17529697 | 0.95 | CYP1A2 (0.43) | CYP1A2NAAATSHRTHRBEPHX1 | |
| SCHEMBL29209988 | 0.95 | CYP1A2 (0.43) | CYP1A2NAAATSHRTHRBEPHX1 | |
| SCHEMBL10597326 | 0.95 | CYP1A2 (0.43) | CYP1A2NAAATSHRTHRBEPHX1 | |
| SCHEMBL1323223 | 0.95 | CYP1A2 (0.43) | CYP1A2NAAATSHRTHRBEPHX1 | |
| SCHEMBL1500600 | 0.95 | CYP1A2 (0.43) | CYP1A2NAAATSHRTHRBEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106488920-A | The preparation method of antiviral compound | 吉利德制药有限责任公司 | 2017-03-08 | — | — | CN | disclosed |
| EP-1683818-B1 | Uretdione formation in solution | COVESTRO DEUTSCHLAND AG (DE) | 2017-03-01 | — | — | EP | disclosed |
| US-8058382-B2 | Uretdione formation in solution | BAYER MATERIALSCIENCE AG (DE) | 2011-11-15 | — | — | US | disclosed |
| US-20060173152-A1 | Uretdione formation in solution | BAYER MATERIALSCIENCE AG | 2006-08-03 | — | — | US | disclosed |
| EP-1683818-A2 | Uretdione formation in solution | Bayer MaterialScience AG (DE) | 2006-07-26 | — | — | EP | disclosed |